Advertisements



MannKind presents positive Afrezza clinical data from STAT, AFFINITY studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

MannKind presents Afrezza clinical data from three studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 9th, 2019

MannKind to present additional "positive" data for Afrezza from STAT study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

MannKind presents Afrezza STAT study data at EASD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

MannKind to present new positive Afrezza clinical data at ATTD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019

Equillium presents "positive" interim clinical data on Itolizumab trial in aGVHD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2021

Verrica Pharmaceuticals presents data from clinical studies of VP-102

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

TG Therapeutics shares rise on early-stage clinical data

Shares of TG Therapeutics Inc. gained 16% in premarket trading on positive data from small early-stage studies testing TG-1701 as .....»»

Category: topSource: marketwatchDec 9th, 2019

NantKwest presents positive Phase 2 Clinical Data for aNK at SITC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 7th, 2019

Applied Genetic presents data from non-clinical studies evaluating AAV vectors

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 21st, 2019

MannKind presents data from one-year study of Afrezza Inhalation Powder

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2019

Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019

-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»

Category: earningsSource: benzingaMay 24th, 2019

iCAD presents "positive" clinical data on Xoft Axxent Electronic eBx system

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 19th, 2018

ResMed Releases Positive U.S. & U.K. Study Data on COPD

ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference. ResMed Inc. RMD recently demonstrated a favorable outcome from two .....»»

Category: dealsSource: nytMay 21st, 2018

Merck Presents Positive Melanoma Data on Keytruda at ASCO

Merck (MRK) presents encouraging data from two pivotal advanced melanoma studies on its PD-L1 inhibitor, Keytruda. Merck & Co., .....»»

Category: personnelSource: nytJun 5th, 2018

Merck (MRK) Presents New Data from Januvia Diabetes Studies

Merck (MRK) produces new data from two studies on type II diabetes medicine Januvia (sitagliptin), which supports the drug's clinical profile. Merck & Co., Inc MRK presented new data from two studies, evaluating its type II di.....»»

Category: dealsSource: nytJun 25th, 2018

Teleflex subsiidiary presents new clinical data from studies of UroLift System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

Bluebird Bio presents updated data from clinical studies of LentiGlobin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 2nd, 2018

Axcella Health presents AXA1665-002 clinical study data at DDW

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

Adagene presents clinical data from NEObody program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

Sarepta"s stock is up 11% on positive data from clinical trial for Duchenne treatment

Shares of Sarepta Therapeutics Inc. gained 11.3% in trading on Tuesday after the co.....»»

Category: topSource: marketwatchMay 18th, 2021